Canntab Therapeutics (FRA:TBF1) Total Stockholders Equity : €-1.50 Mil (As of Feb. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Canntab Therapeutics Total Stockholders Equity?

Canntab Therapeutics's Total Stockholders Equity for the quarter that ended in Feb. 2023 was €-1.50 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Canntab Therapeutics's Book Value per Share for the quarter that ended in Feb. 2023 was €-0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Canntab Therapeutics's Debt-to-Equity for the quarter that ended in Feb. 2023 was -0.88.

Canntab Therapeutics Total Stockholders Equity Historical Data

The historical data trend for Canntab Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canntab Therapeutics Total Stockholders Equity Chart

Canntab Therapeutics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

May17

May18

May19

May20

May21

May22

Total Stockholders Equity

Get a 7-Day Free Trial

2.83

1.51

2.32

1.54

-0.23

Canntab Therapeutics Quarterly Data
	Mar18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23
Total Stockholders Equity	Get a 7-Day Free Trial															0.73	-0.23	-0.56	-1.27	-1.50

Canntab Therapeutics (FRA:TBF1) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Canntab Therapeutics's Book Value per Share for the quarter that ended in Feb. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-1.5	-	0)	/	38.909
	=	-0.04

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Canntab Therapeutics's Debt-to-Equity for the quarter that ended in Feb. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.316	+	0)	/	-1.5
	=	-0.88

Canntab Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Canntab Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Canntab Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canntab Therapeutics Ltd (FRA:TBF1) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9

Website

https://www.canntab.ca

Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of pharmaceutical-grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.

Canntab Therapeutics Headlines

No Headlines